Bharat Immunologicals & Biologicals Corporation Limited (BOM:524663)

India flag India · Delayed Price · Currency is INR
17.08
-0.33 (-1.90%)
At close: Jan 21, 2026
-34.88%
Market Cap761.26M
Revenue (ttm)76.50M
Net Income (ttm)-184.83M
Shares Out43.18M
EPS (ttm)-4.28
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume28,047
Average Volume22,386
Open17.41
Previous Close17.41
Day's Range16.55 - 17.84
52-Week Range16.55 - 29.61
Beta0.41
RSI36.00
Earnings DateOct 31, 2025

About BOM:524663

Bharat Immunologicals & Biologicals Corporation Limited, a biotechnology company, engages in the manufacture and sale of pharmaceutical products in India. It offers oral polio vaccines, zinc tablets, diarrhea management kits, and BIB sweet tablets. The company was incorporated in 1989 and is based in Bulandshahr, India. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1989
Country India
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524663
Full Company Profile

Financial Performance

In 2022, BOM:524663's revenue was 446.09 million, a decrease of -43.09% compared to the previous year's 783.88 million. Losses were -166.39 million, 90.1% more than in 2021.

Financial Statements